Title Image

E-POSTERS

POSTER LIST

Click the button above to find the match of Poster Numbers  against abstract Paper Numbers, or press Ctrl+F to search by name or title.

P01

Farnaz Araghi

The emerging role of T cells in pemphigus vulgaris: a systematic review

P02

Farnaz Araghi

TEN/SJS-like lupus erythematosus presentation complicated

P03

Farnaz Araghi

COVID-19 in pemphigus vulgaris patients with previous rituximab therapy

P04

Meropi Karakioulaki

Treatment of a patient with severe dystrophic epidermolysis bullosa with

P05

Marney White

Characterizing Disability, Quality of Life, and Remission Status

P06

Rey Tristan Joshua

Pemphigoid Gestationis in Pregnancy Decoded

P07

Florentina-Silvia

Gene therapy for skin bullous diseases – where are we?

P08

Harrison Loftus

Psoriasis and Depression: The Role of Inflammation

P09

Harrison Loftus

Pemphigus Vulgaris: Patient-Centered Clinical Pearls

P10

Eirini Kyrmanidou

Netherthon Syndrome: therapeutic approach with dupilumab, our experience

P11

Stephanie Goletz

Diagnosis of anti-p200 pemphigoid

P12

Sierra Parkinson

Nonbullous pemphigoid mimicking arthropod bite reactions in a patient with

P13

Roberto Maglie

Tralokinumab as a novel effective therapy for bullous pemphigoid

 

P14

Charoula Achilla

Association of FOXP3 gene variant rs3761548 with pemphigus vulgaris

P15

Dario Didona

Safety, tolerability, and pharmacokinetics of TPM203, a tolerizing Topas

P16

Anikka Mae Crystal Ollet

A Case of Psoriasis and Pemphigus Foliaceous in a 55-year-old Filipino

P17

Virginia Evdokia Pappa

Bullous pemphigoid in a patient with psoriasis and acquired reactive

P18

Efthymia Karagiannopoulou

Oral Mucosal Telangiectasias As The Only Clinical Sign

P19

Marney White

Gender and Race/Ethnicity in Autoimmune Blistering Diseases: Do Women and

P20

Masahiro Tsutsumi

The improved keratinocyte dissociation assay using desmoglein-knockout

P21

Qijun Wang

Efficacy and safety of different rituximab dosage regimens in pemphigus

P22

Manuela Pigors

Laminin β4 as autoantigen of anti-p200 pemphigoid: pathogenicity and

P23

Sabrina Patzelt

Topical C5aR1 inhibition reduced clinical lesions in a preclinical model of

P24

Eleni Paschou

A real-world observational study of dupilumab treatment in adult patients

P25

Chrysostomos Goulas

Development of bullous pemphigoid during treatment

P26

Suying Feng

Retrospective Analysis of Clinical and Immunoserological

P27

Efterpi Zafiriou

Effective treatment of Bullous Pemphigoid in a patient with nephrotic

P28

Kossara Drenovska

Comedonic pemphigus erythematosus: does it exist?

P29

Dario Didona

Hard as a rock: a case of massive rupioid psoriasis

P30

Nina Kokkonen

The use of dipeptidyl peptidase-4 inhibitors modifies the interplay

P31

Efterpi Zafiriou

Topical Baricitinib in Alopecia Areata: A Case Report

P32

Charlotte Kiehne

 Facilitation of diagnosis of pemphigoid diseases with serum autoantibodies

P33

MA. Bernadette Sedano

Navigating the Complexities of Rupioid Psoriasis

P34

Effimia Stergiadou

Correlation between mucous membrane pemphigoid

P35

Martin Shahid

HLA-DQB1 typing among Bulgarian patients with dermatitis herpetiformis

P36

Anne-Lise Strandmoe

Analysis of the circulating immune profile in pemphigus vulgaris reveals

P37

MA. Bernadette Sedano

Charting New Territory: Chronic Bullous Disease of Childhood in Adolescence

P38

Nikolleta Tsavalopoulou

Immune checkpoint inhibitor induced peristomal localized

P39

Ayrton Michael Gonzales

A Case Of Diffuse Cutaneous Bullous Mastocytosis

P40

Efterpi Zafiriou

Drug- induced bullous pemphigoid in a patient with treatment resistant

P41

Panagiotis Marinos

Localized form of oral lichen planus (OLP) in of the upper lip and gingiva

P42

Anna Vatalachou

When trichoscopy is not enough: a single-center study of clinical

P43

Ezdean Alkurdi

 The Patient’s Perspective: Evaluation of Bullous Pemphigoid

P44

Elia Valeva

Mucous membrane pemphigoid associated with malignancy

P45

Eirini Kyrmanidou

The Hair Diseases Outpatient Clinic of Papageorgiou Hospital

P46

Hana Jedlickova

Mucous membrane pemphigoid diagnostics with western blot analysis

P47

Eleni Stroumpi

Refractory and life threatening pemphigus vulgaris

P48

Bianca Opelka

Epitope-dependent autoantibody-mediated skin inflammation in

P49

Anastasia Tsitlakidou

Antirituximab antibodies – do they play any role in the treatment response

P50

Anissa Zaouak

Nail involvement in pemphigus: a prospective clinical and dermoscopic

P51

Argyroula Papadopoulou

Case Of A Patient With Pemphigus Vulgaris Treated With Rituximab

P52

Efthymia Soura

Demographic data and decision-making processes in patients with

P53

Nikolaos Chaitidis

 Clinical and Epidemiological Characteristics of Gliptin-Induced

P54

Maria Polina Konstantinou 

Epidemiology of Pemphigus in Greece: A 5-year, multicenter Study

P55

Anastasia Tsitlakidou

Advantages of rituximab therapy early in the course of pemphigus

P56

Georgia Pappa

Castleman Disease After A 10-year Period Of Bullous Disease

P57

Agoritsa Gravani

Bullous pemphigoid in Greece: Epidemiological evidence and impact of

P58

Vasiliki Papadopoulou

Erythrodermic Psoriasis: Complete Remission After Administration

P59

Aikaterini Patsatsi

Association of Serum Levels of Total-IgE Autoantibodies With Disease Activity

P60

Aleksandra Lesiak

Epidermolysis Bullosa Acquisita in a 2-Year-Old Girl: A Case Report